| Income statement (USD) | Q2 2026 ended Jun 30, 2026 | Q1 2026 ended Mar 31, 2026 | Q4 2025 ended Dec 31, 2025 | Q3 2025 ended Sep 30, 2025 | Q2 2025 ended Jun 30, 2025 | Q1 2025 ended Mar 31, 2025 | Q4 2024 ended Dec 31, 2024 | Q3 2024 ended Sep 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.80B | 6.96B | 7.92B | 7.77B | 7.08B | 6.67B | 7.57B | 7.54B |
| Cost of revenue | 1.58B | 1.45B | 1.62B | 1.57B | 1.50B | 1.54B | 1.58B | 1.57B |
| Gross profit | 6.22B | 5.51B | 6.30B | 6.20B | 5.58B | 5.13B | 5.99B | 5.97B |
| Research and development | 1.76B | 1.37B | 1.58B | 1.35B | 1.49B | 1.38B | 1.64B | 1.40B |
| Selling, general and admin | 1.92B | 1.45B | 1.79B | 1.36B | 1.36B | 1.26B | 1.91B | 1.43B |
| Operating expenses | 18.20B | 4.37B | 5.94B | 4.44B | 4.61B | 4.43B | 5.12B | 6.66B |
| Operating income | -10.39B | 2.59B | 1.98B | 3.33B | 2.47B | 2.24B | 2.45B | 888.00M |
| EBITDA | -10.30B | 2.68B | 2.07B | 3.42B | 2.57B | 2.33B | 2.55B | 982.00M |
| Interest expense | 247.00M | 240.00M | 255.00M | 256.00M | 254.00M | 260.00M | 249.00M | 238.00M |
| Income before tax | -10.25B | 2.58B | 2.08B | 3.64B | 2.43B | 1.65B | 2.17B | 956.00M |
| Income tax | 242.00M | 559.00M | -105.00M | 589.00M | 468.00M | 334.00M | 385.00M | -297.00M |
| Net income | -10.50B | 2.02B | 2.18B | 3.05B | 1.96B | 1.31B | 1.78B | 1.25B |
| EPS | -8.45 | 1.63 | 1.76 | 2.46 | 1.57 | 1.06 | 1.42 | 1.00 |
| EPS (diluted) | -8.45 | 1.61 | 1.74 | 2.43 | 1.56 | 1.04 | 1.42 | 1.00 |
| Diluted shares | 1.24B | 1.25B | -1.00M | 1.25B | 1.25B | 1.26B | 8.00M | 1.25B |
| Dividends per share | 0.82 | 0.82 | 0.79 | 0.79 | 0.79 | 0.79 | 0.77 | 0.77 |
From Gilead Sciences's 10-K and 10-Q filings with the SEC. Fourth quarters, and quarters where the company only reported year-to-date totals, are worked out by subtracting the earlier quarters. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.
Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.